U.S., Nov. 14 -- ClinicalTrials.gov registry received information related to the study (NCT07935590) titled 'Study of Modzatinib (ATI-2138) in Adult Participants With Biopsy-proven Forms of Lichen Planus Not Adequately Controlled With Topical Therapies' on Nov. 09.
Brief Summary: This study evaluates modzatinib versus placebo in participants with biopsy-proven forms of moderate-to-severe lichen planus (LP).
Study Start Date: Nov., 2026
Study Type: INTERVENTIONAL
Condition:
Lichen Planus
Intervention:
DRUG: Modzatinib
Oral tablets
DRUG: Placebo
Oral tablets
Recruitment Status: NOT_YET_RECRUITING
Sponsor: Aclaris Therapeutics, Inc.
Published by HT Digital Content Services with permission from Health Daily Digest....